Abstracts tagged "nursing roles and rheumatoid arthritis (RA)"

Abstract Number: 2050 • 2016 ACR/ARHP Annual Meeting
Screening for and Management of Comorbidities after a Nurse-Led Program: Results of a 3 Year Longitudinal Study in 776 Established RA Patients
Laure Gossec¹, Martin Soubrier², Frantz Foissac³, Anna Molto⁴, Françoise Fayet⁵, Thomas Bardin⁶, Francis Berenbaum⁷, Alain Cantagrel⁸, Marie Hélène Cerato⁹, Gerard H. Chales¹⁰, Bernard Combe¹¹, Emmanuelle Dernis Labous¹², Isabelle Chary-Valckenaere¹³, Liana Euller-Ziegler¹⁴, Rene-Marc Flipo¹⁵, Philippe Gaudin¹⁶, Melanie Gilson¹⁷, Sandrine Guis¹⁸, Xavier Mariette¹⁹, Gaël Mouterde²⁰, Sophie Pouplin²¹, Pascal Richette²², Alain Saraux²³, Thierry Schaeverbeke²⁴, Jean Sibilia²⁵ and Maxime Dougados²⁶, ¹Rheumatology, Pitié Salpêtrière Hospital, Paris, France, ²Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, ³COMEDRA working group, Paris, France, ⁴Hopital Cochin, Paris Descartes University, Paris, France, ⁵Rheumatology, CHU Gabriel-Montpied, Clermont-Ferrand, France, ⁶Hôpital Lariboisière, Paris, France, ⁷Rheumatology dept, APHP St-Antoine hospital, Univ Paris 06, Paris, France, Paris, France, ⁸Purpan Hospital, Toulouse, France, ⁹University Hospital, Toulouse, France, ¹⁰CHU RENNES, Rennes, France, ¹¹Département Rhumatologie, Hôpital Lapeyronie, Montpellier, France, ¹²Le Mans Hospital, Le Mans, France, ¹³University Hospital, Nancy, France, ¹⁴Rheumatology, Nice, France, ¹⁵Rheumatology, University Hospital, Lille, France, ¹⁶Rheumatology, Grenoble University Hospital, France, Grenoble, France, ¹⁷Hopital Sud, Grenoble, France, ¹⁸Rheumatology 1, CRMBM-CEMEREM 7339, Aix-Marseille Université, AP-HM, CNRS, Marseilles, France, ¹⁹Rheumatology, Rheumatology department, Bicetre Hospital, Paris-Sud University, Le Kremlin Bicetre, France, ²⁰Rheumatology Department, Hopital Lapeyronie, Montpellier, France, ²¹Rheumatology Department & Inserm 905, Department of Rheumatology, Rouen University Hospital & Inserm 905, Institute for Biomedical Research, University of Rouen, Rouen, France, ²²Rhumatologie, Hôpital Lariboisière, Paris, France, ²³Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, ²⁴Rheumatology, CHU Bordeaux, Bordeaux, France, ²⁵Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, ²⁶Paris Descartes University, Paris, France
Background/Purpose: Patients with RA are either more at risk of, or less well screened for, several comorbidities including cardiovascular (CV) risk, cancer, infections and osteoporosis.[1]…
Abstract Number: 1195 • 2015 ACR/ARHP Annual Meeting
Rheumatology Nurse Advice Line in Singapore Tertiary Hospital – Pilot Study
Sow Ling Yee¹, Xiaohui Xin², Rong Fang Zhang³, Hui Yang⁴ and Siaw Ing Yeo⁵, ¹Nursing, Singapore General Hospital, Singapore, Singapore, ²Academic Clinical Programme, Division of Medicine, Singapore General Hospital, Singapore, Singapore, ³Nursing, Singapore General Hospital, S, Singapore, ⁴Division of Medicine, Singapore General Hospital, Singapore, Singapore, ⁵Department of Rheumatology & Immunology, Singapore General Hospital, Singapore, Singapore
Background/Purpose: To evaluate the role of the rheumatology nurse advice line service and the patterns of calls for patient management in an outpatient setting. Methods:…
Abstract Number: 963 • 2013 ACR/ARHP Annual Meeting
Impact Of a Nurse-Led Program On Comorbidity Management In Rheumatoid Arthritis (RA): Results Of a Prospective, Multicenter, Randomized, Controlled Trial
Martin Soubrier¹, Elodie Perrodeau², Melanie Gilson³, Alain G. Cantagrel⁴, Xavier le Loet⁵, René-Marc Flipo⁶, Sandrine Guis⁷, Gael Mouterde⁸, Liana E. Euller-Ziegler⁹, Thierry Schaeverbeke¹⁰, Bruno Fautrel¹¹, Alain Saraux¹², Isabelle Chary-Valckenaere¹³, Gérard Chales¹⁴, Emmanuelle Dernis¹⁵, Pascal Richette¹⁶, Xavier Mariette¹⁷, Francis Berenbaum¹⁸, Jean Sibilia¹⁹, Philippe Ravaud²⁰ and Maxime Dougados²¹, ¹Rheumatology, CHU CLERMONT-FERRAND, Clermont-Ferrand, France, ²Epidemiologist, Paris, France, ³CH Grenoble Hopital Sud, Grenoble, France, ⁴Dept of Rheumatology, Hopital Purpan, Toulouse CEDEX 9, France, ⁵Rheumatology Department, CHU de ROUEN, Rouen, France, ⁶Hôpitaux Universitaires de Lille, France, France, ⁷Rheumatology1, CRMBM UMR CNRS 7339, Aix Marseille Univ; AP-HM, Marseille, France, ⁸Rheumatology, Montpellier 1 University, Lapeyronie Hospital, Montpellier, France, ⁹Service de Rhumatologie, L Archet Hospital (University), Nice CEDEX 3, France, ¹⁰Rhumatology departement, Groupe Hospitalier Pellegrin, Bordeaux, France, ¹¹Rheumatology, UPMC - Paris 6 University, Paris, France, ¹²Rhumatologie, CHU de la Cavale Blanche, Brest Cedex, France, ¹³Rheumatology, Nancy Teaching Hospital, Nancy, France, ¹⁴CHU RENNES, Rennes, France, ¹⁵Centre Hospitalier, Le Mans, France, ¹⁶Centre Viggo Petersen / Service de Rhumatologie, Hôpital Lariboisière, Paris, France, ¹⁷Paris-Sud University, Paris, France, ¹⁸Rheumatology, AP-HP, St Antoine Hospital, Paris, France, ¹⁹Rheumatology, CHU Hautepierre, Strasbourg, France, ²⁰Epidemiology, Hopital Hotel Dieu, Paris Descartes University, Paris, France, ²¹Cochin Hospital, Paris, France
Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of developing numerous comorbid conditions that affect both mortality and RA outcome. Objectives: To…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].